• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码RNA在肝脏疾病中的动态作用:发病机制与诊断方面

Dynamic role of long noncoding RNA in liver diseases: pathogenesis and diagnostic aspects.

作者信息

Chen Ningning, Li Yunxia, Li Xiaoying

机构信息

Department of Neonatology, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital), No. 23976, Jingshi Road, Jinan, 250022, Shandong, China.

School of Basic Medical Sciences, Shandong University, Jinan, China.

出版信息

Clin Exp Med. 2025 May 14;25(1):160. doi: 10.1007/s10238-025-01678-z.

DOI:10.1007/s10238-025-01678-z
PMID:40369230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12078412/
Abstract

Liver disease (LD) is complex pathological condition that has emerged as a major threat to human health and the quality of life. Nonetheless, the molecular mechanisms underlying the pathogenesis of LD have not yet been fully elucidated. Recently, a large amount of evidence has shown that long noncoding RNAs (lncRNAs) play important roles in diverse biological processes in the liver. The dysregulation of lncRNAs in the liver, for example, can affect tumor proliferation, migration, and invasion, contribute to hepatic metabolism disorder of lipid and glucose, and shape of hepatic tumoral microenvironment. Thus, a comprehensive understanding of the functional roles of lncRNAs in LD pathogenesis may provide new perspectives for the development of novel diagnostic and therapeutic tools. In the present review, we summarize the current findings on the relationship between lncRNAs and LD, including the modes of action of lncRNAs, the biological significance of lncRNAs in the pathogenesis of LD, especially in hepatocellular carcinoma (HCC) as well as in some non-neoplastic disorders, and the potential use of lncRNAs as diagnostic biomarkers and therapeutic targets for LD.

摘要

肝脏疾病(LD)是一种复杂的病理状况,已成为对人类健康和生活质量的重大威胁。尽管如此,LD发病机制的分子机制尚未完全阐明。最近,大量证据表明,长链非编码RNA(lncRNAs)在肝脏的多种生物学过程中发挥重要作用。例如,肝脏中lncRNAs的失调可影响肿瘤增殖、迁移和侵袭,导致脂质和葡萄糖的肝脏代谢紊乱,并塑造肝脏肿瘤微环境。因此,全面了解lncRNAs在LD发病机制中的功能作用可能为新型诊断和治疗工具的开发提供新的视角。在本综述中,我们总结了关于lncRNAs与LD之间关系的当前研究结果,包括lncRNAs的作用模式、lncRNAs在LD发病机制中的生物学意义,特别是在肝细胞癌(HCC)以及一些非肿瘤性疾病中的意义,以及lncRNAs作为LD诊断生物标志物和治疗靶点的潜在用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff5f/12078412/d8afc7a78e4a/10238_2025_1678_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff5f/12078412/a730feb55cbf/10238_2025_1678_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff5f/12078412/32b6e5a9c824/10238_2025_1678_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff5f/12078412/f4a6399f7c97/10238_2025_1678_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff5f/12078412/ec7a93faaba1/10238_2025_1678_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff5f/12078412/d8afc7a78e4a/10238_2025_1678_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff5f/12078412/a730feb55cbf/10238_2025_1678_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff5f/12078412/32b6e5a9c824/10238_2025_1678_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff5f/12078412/f4a6399f7c97/10238_2025_1678_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff5f/12078412/ec7a93faaba1/10238_2025_1678_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff5f/12078412/d8afc7a78e4a/10238_2025_1678_Fig5_HTML.jpg

相似文献

1
Dynamic role of long noncoding RNA in liver diseases: pathogenesis and diagnostic aspects.长链非编码RNA在肝脏疾病中的动态作用:发病机制与诊断方面
Clin Exp Med. 2025 May 14;25(1):160. doi: 10.1007/s10238-025-01678-z.
2
The role of long noncoding RNAs in hepatocellular carcinoma.长链非编码 RNA 在肝细胞癌中的作用。
Mol Cancer. 2020 Apr 15;19(1):77. doi: 10.1186/s12943-020-01188-4.
3
Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma.长链非编码RNA(lncRNAs)在肝细胞癌中的研究进展与展望
Cell Physiol Biochem. 2015;36(2):423-34. doi: 10.1159/000430109. Epub 2015 May 11.
4
Long non-coding RNAs: critical players in hepatocellular carcinoma.长链非编码RNA:肝细胞癌中的关键角色。
Int J Mol Sci. 2014 Nov 7;15(11):20434-48. doi: 10.3390/ijms151120434.
5
Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.长链非编码 RNA 在肝细胞癌中的作用:潜在的作用和临床意义。
World J Gastroenterol. 2017 Aug 28;23(32):5860-5874. doi: 10.3748/wjg.v23.i32.5860.
6
Lipid metabolism-related long noncoding RNAs: A potential prognostic biomarker for hepatocellular carcinoma.脂质代谢相关长非编码 RNA:肝细胞癌潜在的预后生物标志物。
World J Gastroenterol. 2024 Sep 7;30(33):3799-3802. doi: 10.3748/wjg.v30.i33.3799.
7
Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.长链非编码RNA作为生物标志物和治疗靶点:肝细胞癌的最新见解
Life Sci. 2017 Dec 15;191:273-282. doi: 10.1016/j.lfs.2017.10.007. Epub 2017 Oct 4.
8
LncRNAs Act as a Link between Chronic Liver Disease and Hepatocellular Carcinoma.长链非编码 RNA 在慢性肝脏疾病与肝细胞癌之间发挥关联作用。
Int J Mol Sci. 2020 Apr 20;21(8):2883. doi: 10.3390/ijms21082883.
9
The Emerging Role of Long Non-Coding RNAs in the Metastasis of Hepatocellular Carcinoma.长链非编码 RNA 在肝细胞癌转移中的新兴作用。
Biomolecules. 2019 Dec 31;10(1):66. doi: 10.3390/biom10010066.
10
Functional long non-coding RNAs in hepatocellular carcinoma.肝细胞癌中的功能性长非编码 RNA。
Cancer Lett. 2021 Mar 1;500:281-291. doi: 10.1016/j.canlet.2020.10.042. Epub 2020 Oct 29.

引用本文的文献

1
The high expression of Long noncoding RNA TEX41 promotes the proliferation, migration, and invasion of hepatocellular carcinoma.长链非编码RNA TEX41的高表达促进肝细胞癌的增殖、迁移和侵袭。
Transl Cancer Res. 2025 May 30;14(5):3175-3185. doi: 10.21037/tcr-2025-812. Epub 2025 May 27.

本文引用的文献

1
Hepatocellular carcinoma: signaling pathways and therapeutic advances.肝细胞癌:信号通路与治疗进展
Signal Transduct Target Ther. 2025 Feb 7;10(1):35. doi: 10.1038/s41392-024-02075-w.
2
The role and function of lncRNA in ageing-associated liver diseases.长链非编码RNA在衰老相关肝脏疾病中的作用与功能。
RNA Biol. 2025 Dec;22(1):1-8. doi: 10.1080/15476286.2024.2440678. Epub 2024 Dec 19.
3
Decreased lncRNA HNF4A-AS1 facilitates resistance to sorafenib-induced ferroptosis of hepatocellular carcinoma by reprogramming lipid metabolism.
lncRNA HNF4A-AS1表达降低通过重编程脂质代谢促进肝癌对索拉非尼诱导的铁死亡的抗性。
Theranostics. 2024 Oct 21;14(18):7088-7110. doi: 10.7150/thno.99197. eCollection 2024.
4
Epidemiology of liver diseases: global disease burden and forecasted research trends.肝脏疾病流行病学:全球疾病负担及预测的研究趋势
Sci China Life Sci. 2025 Feb;68(2):541-557. doi: 10.1007/s11427-024-2722-2. Epub 2024 Oct 16.
5
Frailty and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases.衰弱与代谢功能障碍相关脂肪性肝病及其他慢性肝病的风险
J Hepatol. 2025 Mar;82(3):427-437. doi: 10.1016/j.jhep.2024.08.024. Epub 2024 Aug 31.
6
Dysregulation of Regulatory ncRNAs and Diseases.调控性非编码 RNA 失调与疾病
Int J Mol Sci. 2023 Dec 19;25(1):24. doi: 10.3390/ijms25010024.
7
Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy.环状 RNA 在肝细胞癌免疫治疗中的新兴作用。
Int J Mol Sci. 2023 Nov 18;24(22):16484. doi: 10.3390/ijms242216484.
8
Monocytes subsets altered distribution and dysregulated plasma hsa-miR-21-5p and hsa-miR-155-5p in HCV-linked liver cirrhosis progression to hepatocellular carcinoma.在 HCV 相关肝硬化进展为肝细胞癌的过程中,单核细胞亚群的分布改变和血浆 hsa-miR-21-5p 和 hsa-miR-155-5p 的失调。
J Cancer Res Clin Oncol. 2023 Nov;149(17):15349-15364. doi: 10.1007/s00432-023-05313-w. Epub 2023 Aug 28.
9
LncRNA SNHG1 upregulates FANCD2 and G6PD to suppress ferroptosis by sponging miR-199a-5p/3p in hepatocellular carcinoma.长链非编码 RNA SNHG1 通过海绵吸附 miR-199a-5p/3p 上调 FANCD2 和 G6PD 来抑制肝细胞癌中的铁死亡。
Drug Discov Ther. 2023 Sep 15;17(4):248-256. doi: 10.5582/ddt.2023.01035. Epub 2023 Aug 19.
10
Effect of Vitamin D Supplementation on Primary Dysmenorrhea: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.维生素 D 补充对原发性痛经的影响:随机临床试验的系统评价和荟萃分析。
Nutrients. 2023 Jun 21;15(13):2830. doi: 10.3390/nu15132830.